2020-9-26 16:46 |
Coinspeaker AZN Stock Down 0. 6%, AstraZeneca Receives Partial Immunity from EU in Vaccine DealAstraZeneca has received partial immunity from the EU in a vaccine deal. The EU has already paid €336 million at €2. origin »
|
Coinspeaker Sanofi and GlaxoSmithKline Launch Trials for Their COVID-19 Protein-Based VaccineFrench drugmaker Sanofi and Britain’s GlaxoSmithKline revealed that they had started a clinical trial of their protein-based COVID-19 vaccine candidate, aimed at reaching the final testing stage by December.
Coinspeaker 5 Companies Lead the Race in Producing the First COVID-19 VaccineFive pharmaceutical companies across the globe lead the race in producing the first approved COVID-19 vaccine.
Coinspeaker Moderna (MRNA) Stock Keeps Growing as First Batch of COVID-19 Vaccine Candidate SentModerna Inc (MRNA) stock has been skyrocketing since the company announced its mRNA COVID-19 vaccine has been successfully shipped to the National Institute of Allergy and Infectious Diseases.